In a Tufts CSDD survey of 257 sponsors and CROs, the average time from last patient last visit to database lock was 36.3 days (Wilkinson et al., Therapeutic Innovation & Regulatory Science). In the EU, the trial master file must then be archived for at least 25 years after the trial ends (TransPerfect summary of EU TMF requirements), and a summary of results with a lay summary is due within 12 months of the end of the trial, or 6 months for paediatric trials (TrialAssure, EU CTR and CTIS).
Close-out gets less planning attention than start-up, yet it decides how quickly results reach regulators and how cleanly the trial will stand up to inspection years later. Most close-out delays come from work that could have been done during the trial. Here are seven tasks to keep on schedule.
|
Task |
Owner |
What delays it |
|---|---|---|
|
Data cleaning and query closure |
Data management, sites, CRAs |
Open queries left until after the last visit |
|
Final source data review |
CRAs |
Backlog of unverified critical data |
|
Database lock |
Data management |
Late lab reconciliation or coding |
|
SAE reconciliation |
PV and data management |
EDC and safety database out of step |
|
Site close-out visits |
CRAs, sites |
ISF gaps and unreturned investigational product |
|
Final site payments |
Finance, study managers |
Unreconciled invoices and holdbacks |
|
TMF completion and archiving |
eTMF managers |
Documents missing or never QC'd |
Every open query at last patient last visit is a task between you and database lock. Track query ageing by site through the study, and agree a target for the number of open queries at last visit.
If source data review on critical data is up to date, the final monitoring visits confirm rather than discover. A backlog of unreviewed critical data at the end is one of the most common reasons lock slips.
Serious adverse events in EDC and the safety database must match before lock, and medical coding must be complete. Running reconciliation monthly during the trial leaves only the last few cases for close-out.
The close-out visit checks that the investigator site file is complete, investigational product is reconciled and returned or destroyed, and the site understands its archiving responsibilities. Share the checklist with the site in advance so missing items are found before the visit.
Final payments often include holdbacks, pass-through costs and last visits. Reconciling invoices during the trial makes the final payment a small step rather than a project, and closes the trial on good terms with the site.
Under the EU CTR, sponsors notify each Member State when the trial ends there, and the 12-month results clock starts from the end of the trial. Assign owners for the results summary and lay summary before the last visit.
The TMF should be complete, QC'd and ready to archive with its metadata and audit trail. If a CRO holds the TMF, the transfer to the sponsor needs to be planned, including how documents and their history will move.
Cloudbyz builds CTMS, EDC, eTMF, CTFM and Safety & Pharmacovigilance natively on Salesforce, so close-out tasks across data, documents, payments and safety can be tracked on one platform. CTMS manages close-out visits and milestones by site, EDC supports query management, data review and data export, eTMF supports QC, completeness tracking and export with metadata and audit trail, and CTFM tracks site invoices and payments through to final settlement.
Book a demo or visit cloudbyz.com.